Growth-Biosynthesis Relationships in Erythromycin Fermentation
R L Smith1, H R Bungay, R C Pittenger
1Eli Lilly and Company, Indianapolis, Indiana.
Applied Microbiology
|July 1, 1962
Summary
Erythromycin biosynthesis rates depend on the fermentation medium. Antibiotic production was linked to halted growth in complex media but occurred alongside growth in synthetic media, suggesting medium-specific regulation.
Area of Science:
- Microbiology
- Biochemistry
- Fermentation Technology
Background:
- Erythromycin is a vital antibiotic produced by microorganisms.
- Understanding the regulation of erythromycin biosynthesis is crucial for optimizing production.
- Previous studies have suggested a link between microbial growth and antibiotic synthesis.
Purpose of the Study:
- To investigate how different fermentation media affect the relationship between erythromycin biosynthesis and microbial growth.
- To explore potential autostimulation mechanisms in erythromycin production.
- To establish methods for accurately measuring erythromycin biosynthesis rates.
Main Methods:
- Cultivating microorganisms in two distinct fermentation media: one with a complex nitrogen source and another with a synthetic glycine-based medium.
- Monitoring microbial growth and erythromycin production over time in each medium.
- Investigating the effect of exogenous erythromycin addition on antibiotic production (autostimulation).
- Utilizing labeled precursors to quantify short-term biosynthesis rates.
Main Results:
- The relationship between erythromycin biosynthesis and microbial growth varied significantly based on the fermentation medium.
- In complex nitrogen media, erythromycin production was observed only during periods of growth cessation.
- In synthetic glycine media, erythromycin production occurred concurrently with active microbial growth.
- Autostimulation of erythromycin production was observed upon addition of erythromycin.
- Labeled precursor analysis provided a reliable index for short-term biosynthesis rates.
Conclusions:
- Fermentation medium composition critically influences the regulation of erythromycin biosynthesis relative to microbial growth.
- Glycine-containing synthetic media may offer advantages for synchronized erythromycin production and growth.
- Erythromycin exhibits autostimulatory properties, potentially indicating a feedback mechanism.
- The use of labeled precursors is a valuable tool for precise kinetic analysis of antibiotic biosynthesis.
More Related Videos
Related Concept Videos
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:24Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:23Stringent Response in E. coli
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...